Quality of life of patients with scabies

  title={Quality of life of patients with scabies},
  author={An Jin-gang and Xiao Sheng-xiang and Xiao Sheng-bin and Wei Jun-min and Ge Song-mei and Deng Ying-ying and M Jung-hong and Xu Qing-qiang and Wei Xiao-peng},
  journal={Journal of the European Academy of Dermatology and Venereology},
Background  Scabies is a highly contagious disease caused by the mite Sarcoptes scabiei, and the disease is still a major public health problem in many resource‐poor regions. Apart from the skin lesions or substantial morbidity, scabies also leads to social stigma. However, quality of life (QoL) has not been investigated in patients with scabies. 

Impaired quality of life in adults and children with scabies from an impoverished community in Brazil

A large number of patients with scabies in resource‐poor communities in developing countries are diagnosed with the disease each year and the quality of life of patients is affected by the disease.

Scabies Itch.

Quality of life in patients with scabies in Erbil, Iraq

The disease in its mild, moderate, and severe forms adversely affected patient lives, with no significant association between the severity of the disease and overall quality of life scores.


It is concluded that knowledge, positive attitude and proper treatment is required for reducing the disease burden and quality of life in scabies patients in India.

A study of clinical profile and quality of life in patients with scabies

Feeling of embarrassment, difficulty in work place, social stigmata and depression were frequently observed in patients with scabies, and scabies mildly affected the quality of life in this study.

The elimination of scabies: a task for our generation

Problems still exist with insensitive diagnostic tests, questions concerning mite reservoirs, and restrictions on who can receive ivermectin, but the elimination of scabies in communities worst affected may soon be possible.

Health-related quality of life impact of scabies in the Solomon Islands

The DLQI and CDLQI scores were discriminated between the skin-related QoL of patients with scabies and the control group, indicating that these tools are appropriate to measure skin-based quality of life in the Solomon Islands.

Impact on quality of life in patients with dermatophytosis

The objective of the present study was to assess the quality of life in patients with dermatophytosis.

The Management of Scabies in the 21st Century: Past, Advances and Potentials

Management of scabies remains largely suboptimal from diagnosis to treatment, and progress in the development of new therapeutic measures leading to cure is urgently needed.

Paediatrics: how to manage scabies

This narrative review addresses scabies, a highly contagious, pruritic infestation of the skin caused by the mite Sarcoptes scabiei var hominis, and provides a summary of treatments and recommendations for the management of paediatric scabies.



Scabies: an epidemiologic reassessment.

A reassessment of epidemiologic data questions accepted ideas such as that scabies is a sexually transmitted disease and changes in the immune status of the host population (herd immunity) are epidemiologically significant.

Validation of the Dermatology Life Quality Index among patients with podoconiosis in southern Ethiopia

Quality of life has to date not been assessed among patients with podoconiosis, and the need for further studies to assess this issue is unclear.

Scabies: more than just an irritation

It is established that canine and human scabies populations are genetically distinct, a finding with major implications for the formulation of public health control policies.

Use of the Dermatology Life Quality Index in filarial lymphoedema patients.

Sulfur for Scabies Outbreaks in Orphanages

Sulfur in petrolatum is a safe and cheap choice for mass therapy in children 2 months to 6 years of age affected by scabies outbreaks in two large orphanages in Chiang Mai, Thailand.

Treatment of scabies with 5% permethrin cream: results of a German multicenter study

A 5% permethrin cream formulation (InfectoScab® 5%) was tested in a single‐arm multi‐center study including adults and children from 3 months of age with proven scabies.

Topical Ivermectin: A New Successful Treatment for Scabies

To study the efficacy of ivermectin for scabies, a trial with this drug that could be easily administered, with fast application and high efficacy, was undertaken and found that all patients were cured, tolerated the medication well, and there were no side effects or signs of recurrence 2, 4, or 6 weeks after therapy.

The use of ivermectin in controlling an outbreak of scabies in a prison

Ivermectin is an effective and safe treatment for scabies, particularly in a closed community, such as a prison, where it is easy to administer and avoids problems with compliance.

Post-streptococcal acute glomerulonephritis : A clinical, bacteriological and serological study

  • S. Rajajee
  • Medicine
    Indian journal of pediatrics
  • 1990
The disease had an excellent prognosis in these children admitted with Acute poststreptococcal glomerulonephritis and none of those examined 2 years after discharge had proteinuria or hypertension.